Dupilumab in Children with Moderate-to-Severe Asthma: a cost utility analysis. Buendia JA, Patino DG. Pediatr Pulmonol 2022 Jun 6. doi: 10.1002/ppul.26033.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Buendia JA, Patino DG. Dupilumab in Children with Moderate-to-Severe Asthma: a cost utility analysis. Pediatr Pulmonol 2022 Jun 6. doi: 10.1002/ppul.26033.
PMID: 35668042